Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 24,133 | 21,655 | 10,319 | 20,805 | 22,187 |
| Gross Profit | 24,133 | 21,655 | 10,319 | 20,805 | 22,187 |
| Operating Expenses | 50,839 | 43,853 | 46,140 | 45,740 | 41,589 |
| Operating Income | -26,706 | -22,198 | -35,821 | -24,935 | -19,402 |
| Other Income | 82 | -66 | 71 | 81 | 815 |
| Pre-tax Income | -26,624 | -22,264 | -35,750 | -24,854 | -18,587 |
| Net Income Continuous | -26,624 | -22,264 | -35,750 | -24,854 | -18,587 |
| Net Income | $-26,624 | $-22,264 | $-35,750 | $-24,854 | $-18,587 |
| EPS Basic Total Ops | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 |
| EPS Basic Continuous Ops | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 |
| EPS Diluted Total Ops | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 |
| EPS Diluted Continuous Ops | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 |
| EBITDA(a) | $-25,225 | $-20,649 | $-33,599 | $-23,072 | $-18,542 |